About

Radiologex® is the world’s first Medical Interactive Network™ (MIN™), an all-encompassing technological ecosystem facilitated by means of blockchain technology, which empowers users with the necessary tools to conduct a myriad of tasks and activities all in one place. Radiologex, or R-DEE® for short (Radiologex Digital Encryption Environment), is a revolutionary software platform and digital global network for healthcare industry professionals and participants alike that is user-friendly, ultra-fast and exceedingly secure.

Click to see more

STO’S Details

  • GENERAL INFORMATION
  • Pre-STO Opening Date:

    To be announced (UTC)

  • Pre-STO Closing Date:

    To be announced (UTC)

  • STO Opening Date:

    To be announced (UTC)

  • STO Closing Date:

    To be announced (UTC)

  • Country of Origin:

    USA

  • TOKEN DETAILS
  • Symbol:

  • Blockchain Type:

  • Token Type:

  • Finance Information
  • Tokens for Sale:

    100 000 000

  • Initial Token Price:

    1 = 1 USD

  • Hard Cap:

    20 000 000USD

  • Min. investment:

    5000 USD

  • legal INFORMATION
  • Company Name:

    Radiologex Technologies LLC.

  • Country of Incorporation:

    USA

  • Company Address:

    16460 Bake Parkway Irvine, CA 92618

  • Whitelist:

  • Know Your Customer (KYC):

    Required

  • Anti-Money Laundering (AML):

    Required

Team

  • John-Kiyo Smith

    John-Kiyo Smith

    CEO

  • George Tyler

    George Tyler

    CTO

  • Sana Khan, M.D

    Sana Khan, M.D

    CMO

Initial Offering News
Elon Musk Grok AI Predicts Solana Could Hit $400+ By 2027
By September 13th, 2026
Token Sales News Elon Musk Grok AI Predicts Solana Could Hit $400+ By 2027
By September 13th, 2026

The Elon Musk-backed Grok AI predicts that by January 1, 2027, Solana (SOL) could trade around $350–$450, with a target range of $380–$420, assuming a full-blown crypto bull market returns by late 2026. As of September 13, 2026, SOL trades just above $100, significantly below its January 2025 all-time high of around $295–$296. This outlook […]